Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Richard Barry Parad, M.D.

Title
Institution
Department
Address
Phone
Fax

Mentoring
The Expression of Bacterial Permeability - Increasing Proteina nd Monocyte/Neutrophil Elastase Inhibitor in Newborns of Different Gestational Ages
Summer, 06/21/99 - 08/20/99
Study of Innate Defense in Critically Ill Premature Neonates: Measurement of Bactericidal/Permeability - Increasing Protein in the Tracheal Aspirate Derived Neutrophils
Part Time/Continuation, 09/01/00 - 02/28/01
Study of Innate Defense In Critically Ill Premature Neonates: Measurementof Bactericidal/Permeability Increasing Protein in the New Tracheal Aspirate-derived Neutrophils
Summer/Continuation, 06/17/00 - 08/31/00
Study of Innate Defense in Critically Il Premature Neonates
Part Time, 02/01/00 - 06/16/00

Research
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
  1. R01HG002097 (PARAD, RICHARD B) Sep 30, 2001 - Aug 31, 2005
    NIH/NHGRI
    Parent Education on DNA Testing in the Newborn Screen
    Role: Principal Investigator
  2. K08DK002273 (PARAD, RICHARD B) Jul 1, 1993 - Jun 30, 1999
    NIH/NIDDK
    ASSOCIATION OF CFTR MUTATIONS AND BORDERLINE SWEAT TESTS
    Role: Principal Investigator

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Davis JM, Pilon AL, Shenberger J, Breeze JL, Terrin N, Mazela J, Gulczynska E, Lauterbach R, Parad R. The role of recombinant human CC10 in the prevention of chronic pulmonary insufficiency of prematurity. Pediatr Res. 2019 May 13. PMID: 31086287.
    Citations:    
  2. Ceyhan-Birsoy O, Murry JB, Machini K, Lebo MS, Yu TW, Fayer S, Genetti CA, Schwartz TS, Agrawal PB, Parad RB, Holm IA, McGuire AL, Green RC, Rehm HL, Beggs AH. Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. Am J Hum Genet. 2019 Jan 03; 104(1):76-93. PMID: 30609409.
    Citations:    Fields:    
  3. Parad RB, Winston AB, Kalish LA, Gupta M, Thompson I, Sheldon Y, Morey J, Van Marter LJ. Role of Genetic Susceptibility in the Development of Bronchopulmonary Dysplasia. J Pediatr. 2018 12; 203:234-241.e2. PMID: 30287068.
    Citations:    Fields:    
  4. Genetti CA, Schwartz TS, Robinson JO, VanNoy GE, Petersen D, Pereira S, Fayer S, Peoples HA, Agrawal PB, Betting WN, Holm IA, McGuire AL, Waisbren SE, Yu TW, Green RC, Beggs AH, Parad RB. Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. Genet Med. 2019 03; 21(3):622-630. PMID: 30209271.
    Citations:    Fields:    
  5. Murry JB, Machini K, Ceyhan-Birsoy O, Kritzer A, Krier JB, Lebo MS, Fayer S, Genetti CA, VanNoy GE, Yu TW, Agrawal PB, Parad RB, Holm IA, McGuire AL, Green RC, Beggs AH, Rehm HL. Reconciling newborn screening and a novel splice variant in BTD associated with partial biotinidase deficiency: a BabySeq Project case report. Cold Spring Harb Mol Case Stud. 2018 08; 4(4). PMID: 29728376.
    Citations:    Fields:    
  6. Holm IA, Agrawal PB, Ceyhan-Birsoy O, Christensen KD, Fayer S, Frankel LA, Genetti CA, Krier JB, LaMay RC, Levy HL, McGuire AL, Parad RB, Park PJ, Pereira S, Rehm HL, Schwartz TS, Waisbren SE, Yu TW, Green RC, Beggs AH. The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018 07 09; 18(1):225. PMID: 29986673.
    Citations:    Fields:    
  7. Sontag MK, Sarkar D, Comeau AM, Hassell K, Botto LD, Parad R, Rose SR, Wintergerst KA, Smith-Whitley K, Singh S, Yusuf C, Ojodu J, Copeland S, Hinton CF. Case Definitions for Conditions Identified by Newborn Screening Public Health Surveillance. Int J Neonatal Screen. 2018; 4(2):16. PMID: 29862374.
    Citations:    
  8. Parad RB. Non-sedation of the neonate for radiologic procedures. Pediatr Radiol. 2018 04; 48(4):524-530. PMID: 29550867.
    Citations:    Fields:    Translation:Humans
  9. Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, Sommerburg O, Accurso FJ, Davies JC, Rock MJ, Sanders DB, Wilschanski M, Sermet-Gaudelus I, Blau H, Gartner S, McColley SA. Diagnosis of Cystic Fibrosis in Screened Populations. J Pediatr. 2017 02; 181S:S33-S44.e2. PMID: 28129810.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  10. Berg JS, Agrawal PB, Bailey DB, Beggs AH, Brenner SE, Brower AM, Cakici JA, Ceyhan-Birsoy O, Chan K, Chen F, Currier RJ, Dukhovny D, Green RC, Harris-Wai J, Holm IA, Iglesias B, Joseph G, Kingsmore SF, Koenig BA, Kwok PY, Lantos J, Leeder SJ, Lewis MA, McGuire AL, Milko LV, Mooney SD, Parad RB, Pereira S, Petrikin J, Powell BC, Powell CM, Puck JM, Rehm HL, Risch N, Roche M, Shieh JT, Veeraraghavan N, Watson MS, Willig L, Yu TW, Urv T, Wise AL. Newborn Sequencing in Genomic Medicine and Public Health. Pediatrics. 2017 Feb; 139(2). PMID: 28096516.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  11. Ceyhan-Birsoy O, Machini K, Lebo MS, Yu TW, Agrawal PB, Parad RB, Holm IA, McGuire A, Green RC, Beggs AH, Rehm HL. A curated gene list for reporting results of newborn genomic sequencing. Genet Med. 2017 07; 19(7):809-818. PMID: 28079900.
    Citations: 5     Fields:    Translation:HumansCells
  12. Salinas DB, Azen C, Young S, Keens TG, Kharrazi M, Parad RB. Phenotypes of California CF Newborn Screen-Positive Children with CFTR 5T Allele by TG Repeat Length. Genet Test Mol Biomarkers. 2016 Sep; 20(9):496-503. PMID: 27447098.
    Citations:    Fields:    Translation:HumansCells
  13. Afacan O, Gholipour A, Mulkern RV, Barnewolt CE, Estroff JA, Connolly SA, Parad RB, Bairdain S, Warfield SK. Fetal lung apparent diffusion coefficient measurement using diffusion-weighted MRI at 3 Tesla: Correlation with gestational age. J Magn Reson Imaging. 2016 12; 44(6):1650-1655. PMID: 27159847.
    Citations: 1     Fields:    Translation:HumansCells
  14. Parad RB, Davis JM, Lo J, Thomas M, Marlow N, Calvert S, Peacock JL, Greenough A. Prediction of respiratory outcome in extremely low gestational age infants. Neonatology. 2015; 107(4):241-8. PMID: 25765705.
    Citations: 4     Fields:    Translation:Humans
  15. Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R, Barben J, Southern KW. Cystic Fibrosis Screen Positive, Inconclusive Diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. J Cyst Fibros. 2015 Nov; 14(6):706-13. PMID: 25630966.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  16. Bhattacharjee A, Sokolsky T, Wyman SK, Reese MG, Puffenberger E, Strauss K, Morton H, Parad RB, Naylor EW. Development of DNA confirmatory and high-risk diagnostic testing for newborns using targeted next-generation DNA sequencing. Genet Med. 2015 May; 17(5):337-47. PMID: 25255367.
    Citations: 12     Fields:    Translation:HumansPHPublic Health
  17. Lakshmanan A, Leeman KT, Brodsky D, Parad R. Evaluation of a web-based portal to improve resident education by neonatology fellows. Med Educ Online. 2014; 19:24403. PMID: 25059834.
    Citations: 2     Fields:    Translation:Humans
  18. Ren CL, Parad R, Borowitz D. Indeterminate cystic fibrosis newborn screening results. Pediatr Pulmonol. 2015 Feb; 50(2):209-10. PMID: 24760681.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  19. Lakshmanan A, Leeman KT, Brodsky D, Parad R. Evaluation of a web-based portal to improve resident education by neonatology fellows. Med Educ Online. 2014 Jan; 19(1):24403. PMID: 28440174.
    Citations:    
  20. Glotzbecker MP, Estroff JA, Curtis TA, Kalish LA, Spencer SA, Parad RB, Kasser JR, Mahan ST. Prospective evaluation of a prenatal sonographic clubfoot classification system. Fetal Diagn Ther. 2013; 34(4):236-40. PMID: 24135764.
    Citations:    Fields:    Translation:Humans
  21. Levesque BM, Kalish LA, Winston AB, Parad RB, Hernandez-Diaz S, Phillips M, Zolit A, Morey J, Gupta M, Mammoto A, Ingber DE, Van Marter LJ. Low urine vascular endothelial growth factor levels are associated with mechanical ventilation, bronchopulmonary dysplasia and retinopathy of prematurity. Neonatology. 2013; 104(1):56-64. PMID: 23711562.
    Citations: 8     Fields:    Translation:Humans
  22. Nathe KE, Mancuso CJ, Parad R, Van Marter LJ, Martin CR, Stoler-Barak L, Philbin VJ, Phillips MF, Palmer CD, Levy O. Innate immune activation in neonatal tracheal aspirates suggests endotoxin-driven inflammation. Pediatr Res. 2012 Aug; 72(2):203-11. PMID: 22580716.
    Citations: 2     Fields:    Translation:Humans
  23. Parad RB, Allred EN, Rosenfeld WN, Davis JM. Reduction of retinopathy of prematurity in extremely low gestational age newborns treated with recombinant human Cu/Zn superoxide dismutase. Neonatology. 2012; 102(2):139-44. PMID: 22710821.
    Citations: 11     Fields:    Translation:Humans
  24. Parad RB. Update on the diagnosis and management of bronchopulmonary dysplasia/chronic lung disease of infancy: what the radiologist should know. Pediatr Radiol. 2012 Jan; 42 Suppl 1:S92-100. PMID: 22395721.
    Citations: 1     Fields:    Translation:Humans
  25. Als H, Duffy FH, McAnulty G, Butler SC, Lightbody L, Kosta S, Weisenfeld NI, Robertson R, Parad RB, Ringer SA, Blickman JG, Zurakowski D, Warfield SK. NIDCAP improves brain function and structure in preterm infants with severe intrauterine growth restriction. J Perinatol. 2012 Oct; 32(10):797-803. PMID: 22301525.
    Citations: 15     Fields:    Translation:Humans
  26. Keiles S, Koepke R, Parad R, Kharrazi M. Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening. J Cyst Fibros. 2012 May; 11(3):257-60. PMID: 22209734.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  27. Nguyen RH, Umbach DM, Parad RB, Stroehla B, Rogan WJ, Estroff JA. US assessment of estrogen-responsive organ growth among healthy term infants: piloting methods for assessing estrogenic activity. Pediatr Radiol. 2011 May; 41(5):633-42. PMID: 21104239.
    Citations: 4     Fields:    Translation:HumansAnimals
  28. Labrecque M, Parad RB, Gupta M and Hansen A. Donation after Cardiac Death: The Potential Contribution of an Infant Organ Donor Population. J Pediatr. 2010; in press..
  29. Glotzbecker MP, Estroff JA, Spencer SA, Bosley JC, Parad RB, Kasser JR, Mahan ST. Prenatally diagnosed clubfeet: comparing ultrasonographic severity with objective clinical outcomes. J Pediatr Orthop. 2010 Sep; 30(6):606-11. PMID: 20733428.
    Citations: 4     Fields:    Translation:Humans
  30. Labrecque M, Parad R, Gupta M, Hansen A. Donation after cardiac death: the potential contribution of an infant organ donor population. J Pediatr. 2011 Jan; 158(1):31-6. PMID: 20732689.
    Citations: 3     Fields:    Translation:Humans
  31. Als H, Duffy FH, McAnulty GB, Fischer CB, Kosta S, Butler SC, Parad RB, Blickman JG, Zurakowski D, Ringer SA. Is the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) effective for preterm infants with intrauterine growth restriction? J Perinatol. 2011 Feb; 31(2):130-6. PMID: 20651694.
    Citations: 8     Fields:    Translation:Humans
  32. Parad RB. HFOV in preterms: an individual patients' data meta-analysis. Lancet. 2010 Jun 12; 375(9731):2054-5. PMID: 20549868.
    Citations: 1     Fields:    Translation:Humans
  33. Hale JE, Parad RB, Dorkin HL, Gerstle R, Lapey A, O'Sullivan BP, Spencer T, Yee W, Comeau AM. Cystic fibrosis newborn screening: using experience to optimize the screening algorithm. J Inherit Metab Dis. 2010 Oct; 33(Suppl 2):S255-61. PMID: 20521170.
    Citations: 5     Fields:    Translation:HumansPHPublic Health
  34. Als H, Duffy, FH, McAnulty G, Fischer CB, Kosta S, Butler SC, Parad RB, Blickman JG, Zurakowski D, Ringer SA. Is the Newborn Individualized Developmental Care and Assessment Program (NIDCAP) Effective for Preterm Infants with Intrauterine Growth Restriction?. Journal of Perinatology. 2010; In press.
  35. Glotzbecker M, Estroff JA, Spencer S, Bosley JC, Parad RB, Kasser JR, Mahan ST. Prenatally diagnosed clubfeet: Comparing ultrasonographic severity with objective clinical outcomes. Journal of Pediatric Orthopaedics. 2010; in press.
  36. Marchione, Marilynn . AP IMPACT: Testing curbs some genetic diseases (Associated Press interview by Marilynn Marchione): http://www.npr.org/templates/story/story.php?storyId=123798798 http://abcnews.go.com/Technology/wireStory?id=9877649 http://news.yahoo.com/s/ap/20100218/ap_on_sc/us_med_gene_testing http://www.washingtonpost.com/wp-dyn/content/article/2010/02/21/AR2010022101704.html http://www.foxnews.com/story/0,2933,586331,00.html,http://www.cnbc.com/id/35369312/ http://www.nytimes.com/aponline/2010/02/18/science/AP-US-MED-Gene-Testing.html?ref=aponline. 2010.
  37. Borowitz D, Parad RB, Sharp JK, Sabadosa KA, Robinson KA, Rock MJ, Farrell PM, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation practice guidelines for the management of infants with cystic fibrosis transmembrane conductance regulator-related metabolic syndrome during the first two years of life and beyond. J Pediatr. 2009 Dec; 155(6 Suppl):S106-16. PMID: 19914443.
    Citations: 28     Fields:    Translation:Humans
  38. Borowitz D, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL, Michel SH, Parad RB, White TB, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation evidence-based guidelines for management of infants with cystic fibrosis. J Pediatr. 2009 Dec; 155(6 Suppl):S73-93. PMID: 19914445.
    Citations: 57     Fields:    Translation:HumansPHPublic Health
  39. Borowitz D, Parad RB, Sharp JS, Sabadosa KA, Robinson KA, Rock MJ, Farrell PN, Sontag MK, Rosenfeld M, Davis SD, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation Practice Guidelines for the Management of Infants with Cystic Fibrosis Transmembrane Conductance Regulator-Related Metabolic Syndrome during the First Two Years of Life and Beyond . J Peds. 2009; 155(6, Supplement 1):S71-S116 .
  40. Borowitz B, Robinson KA, Rosenfeld M, Davis SD, Sabadosa KA, Spear SL Michel SH, Parad RP, White T, Farrell PM, Marshall BC, Accurso FJ. Cystic Fibrosis Foundation Evidence-Based Guidelines for Management of Infants with Cystic Fibrosis. J Peds. 2009; 155(6, Supplement 1):S71-S116.
  41. McAnulty G, Duffy FH, Butler S, Parad R, Ringer S, Zurakowski D, Als H. Individualized developmental care for a large sample of very preterm infants: health, neurobehaviour and neurophysiology. Acta Paediatr. 2009 Dec; 98(12):1920-6. PMID: 19735497.
    Citations: 9     Fields:    Translation:Humans
  42. Steven Keile, Ruth Koepke, Richard Parad, Martin Kharrazi, California CF Newborn Screening Consortium. Impact of IVS8-(TG)m(T)n Haplootype on Immunorreactive Trypsinogen (IRT) and Sweat Chloride (SC) Levels in a Cohort of Hypertrypsinogenemic (HT) Newborns with Genotype DF508/5T Identified by the California (CA) Cystic Fibrosis (CF) Newborn Screen (NBS) . Ped Pulmonol. 2009.
  43. Nathe KE, Parad R, Van Marter LJ, Lund CA, Suter EE, Hernandez-diaz S, Boush EB, Ikonomu E, Gallington L, Morey JA, Zeman AM, Mcnamara M, Levy O. Endotoxin-directed innate immunity in tracheal aspirates of mechanically ventilated human neonates. Pediatr Res. 2009 Aug; 66(2):191-6. PMID: 19390484.
    Citations: 6     Fields:    Translation:HumansAnimalsCells
  44. Nathe K, Stoler-Barak L, Philbin V, Parad R, Van Marter L, Levy O . Early Activation of an Innate Immune Transcriptome and Identification of Calgranulin C Expression. Ped Research. 2009.
  45. Levesque B, Hernandez-Diaz S, Parad R, Phillips M, Gupta M, Ingber D, Van Marter L . BPD: Clinical Results Title: Urinary Vascular Endothelial Growth Factor (VEGF): Correlation with Mechanical Ventilation and Bronchopulmonary Dysplasia (BPD) in Infants Born before 29 Weeks Gestation. Ped Research. 2009.
  46. Welty S, Lynch S, O’Shea TM, Malcolm W, Kallapur S, Auten R, Martin R,Truog W, Nelin L, Nogee L, Parad RB, Abman S, Bancalari E, Walsh M. 2009 BPD Roundtable: http://www.nationwidechildrens.org/bpd-roundtable. 2009.
  47. Carlson D, McKeen E, Mitchell M, Torres B, Parad R, Comeau AM, O'Sullivan BP. Oropharyngeal flora in healthy infants: observations and implications for cystic fibrosis care. Pediatr Pulmonol. 2009 May; 44(5):497-502. PMID: 19360845.
    Citations: 3     Fields:    Translation:HumansCells
  48. Parad R, Davis J, Marlow N, Peacock J, Calvert S, Greenough A . A Chronic Respiratory Morbidity (CRM) Definition Derived from 12 Month (M) Respiratory Symptom Diaries (RD) Predicts 12m Pulmonary Function (PFT) and 24m Respiratory Health in Extremely Low Gestational Age Newborns (ELGANs). Ped Research. 2009.
  49. Michael P Glotzbecker MD, Judy A Estroff MD, Susan T Mahan MD, MPH, Justin C Bosley, Richard B Parad MD MPH, Samantha A Spencer, MD, James R Kasser MD . Prenatally Diagnosed Clubfeet: Comparing Ultrasonographic Severity with Clinical Outcomes. http://posna.gmetonline.com/ViewPresentation.aspx?subscriptionpackageid=31. 2009.
  50. McBride JA, Parad RB, Davis JM, Zheng Z, Zupancic JA. Economic evaluation of recombinant human copper zinc superoxide dismutase administered at birth to premature infants. J Perinatol. 2009 May; 29(5):364-71. PMID: 19225525.
    Citations: 1     Fields:    Translation:Humans
  51. Davis J, Parad R. The Use of Antioxidants to Prevent or Ameliorate Bronchopulmonary Dysplasia (Chapter 26). Abman S, ed. Bronchopulmnary Dysplasia (Lung Biology in Health and Disease Vol 240, Lenfant C ed.). 2009; 458-471.
  52. Baby's first test: Newborn Screening. 2008.
  53. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, Durie PR, Legrys VA, Massie J, Parad RB, Rock MJ, Campbell PW. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008 Aug; 153(2):S4-S14. PMID: 18639722.
    Citations: 172     Fields:    Translation:HumansPHPublic Health
  54. Hale JE, Parad RB, Comeau AM. Newborn screening showing decreasing incidence of cystic fibrosis. N Engl J Med. 2008 Feb 28; 358(9):973-4. PMID: 18305279.
    Citations: 13     Fields:    Translation:HumansPHPublic Health
  55. Parad R. Bronchopulmonary Dysplasia. Manual of Neonatal Care (Cloherty JP, Eichenwald, EC, Stark AR, editors). 2007.
  56. Green R. Summary of Workgroup Meeting on Use of Family History Information in Pediatric Primary Care and Public Health. Pediatrics. 2007; 120(Supplement 2):S87-S100.
  57. Comeau AM, Accurso FJ, White TB, Campbell PW, Hoffman G, Parad RB, Wilfond BS, Rosenfeld M, Sontag MK, Massie J, Farrell PM, O'Sullivan BP. Guidelines for implementation of cystic fibrosis newborn screening programs: Cystic Fibrosis Foundation workshop report. Pediatrics. 2007 Feb; 119(2):e495-518. PMID: 17272609.
    Citations: 28     Fields:    Translation:HumansPHPublic Health
  58. Nathe K, Suter E, Lund C, Parad R, Morey J, Van Marter L, Levy O. Endotoxin-directed innate immunity in tracheal aspirates of critically ill premature human neonates: Mobilization of bactericidal permeability increasing protein (BPI), LPS-Binding Protein, and Soluble CD14. Pediatric Research. 2007.
  59. Parad R, Allred E, Rosenfeld W, Davis J. Incidence and Severity of Retinopathy of Prematurity (ROP) is Reduced in Extremely Low Gestational Age (GA) Newborns (ELGANS) Treated with Recombinant Human Cu/Zn Superoxide Dismutase (rhSOD). Pediatric Research. 2007; E-PAS2007:618225.6.
  60. O'Sullivan BP, Zwerdling RG, Dorkin HL, Comeau AM, Parad R. Early pulmonary manifestation of cystic fibrosis in children with the DeltaF508/R117H-7T genotype. Pediatrics. 2006 Sep; 118(3):1260-5. PMID: 16951024.
    Citations: 5     Fields:    Translation:HumansCellsPHPublic Health
  61. Estroff J, Parad R, Stroehla B, Umbach D and Rogan W. Developing Methods for Studying Estrogen-like Effects of Soy Isoflavones in Infants 3: Ultrasound . PAS. 2006.
  62. Van Marter L, Allred E, Morey J, Parad R, Vitali S, Kourembanas S. Bilirubin and Bronchopulmonary Dysplasia Among Extremely Low Gestational Age Newborns. PAS. 2006.
  63. Parad R. Family History and Single Gene Disorders: Cystic Fibrosis. Use of Family History Information in Pediatric Primary Care and Public Health, a Workgroup at Centers for Disease Control and Prevention National Center on Birth Defects and Developmental Disabilities. 2006; http://www.cdc.gov/ncbddd/bd/f.
  64. Parad R, Allred E, Davis J . Incidence And Severity of Retinopathy of Prematurity (Rop) is Reduced in Extremely Low Gestational Age (GA) Newborns (ELGANs) Treated with Recombinant Human Cu/Zn Superoxide Dismutase (rhSOD). Journal of European Pediatrics. 2006.
  65. Estroff J, Wong J, Parad R, Tanden R, Barnewolt C,. Accuracy of Prenatal Imaging of Fetal Cleft Palate by MRI. Presented at IFMSS, Kona, Hawaii. 2006.
  66. Lang J E, Forbes P J, Parchesky A, Little M, Hale J, Parad R, Comeau A, Waltz D A. Safety, Feasibility, and Quality Assurance of Sweat Testing in Newborn Infants. Pediatric Pulmonology. 2006.
  67. Parad, R and Ren, C. Role of the CF Clinician in the Implementation and Maintenance of CF Newborn Screening Programs. 2005.
  68. Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Communications systems and their models: Massachusetts parent compliance with recommended specialty care after positive cystic fibrosis newborn screening result. J Pediatr. 2005 Sep; 147(3 Suppl):S98-100. PMID: 16202793.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  69. Comeau AM, Parad R, Gerstle R, O'Sullivan BP, Dorkin HL, Dovey M, Haver K, Martin T, Eaton RB. Challenges in implementing a successful newborn cystic fibrosis screening program. J Pediatr. 2005 Sep; 147(3 Suppl):S89-93. PMID: 16202791.
    Citations: 1     Fields:    Translation:HumansPHPublic Health
  70. Wilfond BS, Parad RB, Fost N. Balancing benefits and risks for cystic fibrosis newborn screening: implications for policy decisions. J Pediatr. 2005 Sep; 147(3 Suppl):S109-13. PMID: 16202773.
    Citations: 4     Fields:    Translation:HumansPHPublic Health
  71. Parad RB, Comeau AM, Dorkin HL, Dovey M, Gerstle R, Martin T, O'Sullivan BP. Sweat testing infants detected by cystic fibrosis newborn screening. J Pediatr. 2005 Sep; 147(3 Suppl):S69-72. PMID: 16202787.
    Citations: 9     Fields:    Translation:HumansPHPublic Health
  72. Parad RB, Comeau AM. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm. J Pediatr. 2005 Sep; 147(3 Suppl):S78-82. PMID: 16202789.
    Citations: 7     Fields:    Translation:HumansPHPublic Health
  73. Parad R, Comeau A, Soultan Z, Anbar R, Pass K, Caggana M, Dorkin H, Quizon A, Waltz D, Martin M, Schechter M, Borowitz D, Voter K, Ren C, Dozor A, Kaslovsky R, Comber P, O’Sullivan B . Outcomes of a Cohort of Immunoreactive Trypsinogen (IRT)/DNA Cystic Fibrosis Newborn Screening (CFNBS) Positive Infants with R117H as One of Two Detected CFTR Mutations: Worrisome Throat Culture Findings. Pediatr Pulmonology. 2005; S28:256.
  74. Parad, R, Farrell, P, Campbell, P. Newborn Screening for Cystic Fibrosis: Evaluation of Benefits and Risks and Recommendations for State Newborn Screening Programs. J Pediatr 147(3):. 2005; 147(3 (Supplement 1)):S1-S114 .
  75. Parad RB, Comeau AM, Hale J. Removal of CFTR mutation R117H from the cystic fibrosis (CF) newborn screening (NBS) mutation panel would decrease detection of atypical CF. Pediatric Academic Societies Meeting. PAS. 2005; 57:2311.
  76. McBride J, Parad R, Davis J, Allred L, Zupancic J. Cost analysis on the use of recombinant human superoxide dismutase (rhSOD) at birth in preterm infants to improve pulmonary outcome. PAS. 2005; 57:1232.
  77. Comeau AM, Parad RB, Dorkin HL, Dovey M, Gerstle R, Haver K, Lapey A, O'Sullivan BP, Waltz DA, Zwerdling RG, Eaton RB. Population-based newborn screening for genetic disorders when multiple mutation DNA testing is incorporated: a cystic fibrosis newborn screening model demonstrating increased sensitivity but more carrier detections. Pediatrics. 2004 Jun; 113(6):1573-81. PMID: 15173476.
    Citations: 25     Fields:    Translation:HumansPHPublic Health
  78. Parad RB, Comeau AM, Dovey M, Martin T, Dorkin H, O’Sullivan B, Gerstle R. Prevalence of immunoreactive trypsinogen (IRT) level below newborn screen cutoff in CF that presents with meconium ileus. Eighteenth Annual North American Cystic Fibrosis Conference, St. Louis, MO. Ped Pulm. 2004; S27:226.
  79. Parad RB, Estrella E, Comeau AM, Hawley P. Attitute toward CF newborn screening after receiving false positive results: Impact of genetic counseling on parents identified as carriers. Eighteenth Annual North American Cystic Fibrosis Conference, St. Louis, MO. Pediatr Pulmonol. 2004; S27:226-227.
  80. Ward VL, Barnewolt CE, Estroff JA, Levine D, Mehta TS, Parad RB. Work-in-Progress for the SPR Millennium Grant: Fetal MR of Chest Masses. The Society for Pediatric Radiology. 2004.
  81. Als H, Gilkerson L, Duffy FH, McAnulty GB, Buehler DM, Vandenberg K, Sweet N, Sell E, Parad RB, Ringer SA, Butler SC, Blickman JG, Jones KJ. A three-center, randomized, controlled trial of individualized developmental care for very low birth weight preterm infants: medical, neurodevelopmental, parenting, and caregiving effects. J Dev Behav Pediatr. 2003 Dec; 24(6):399-408. PMID: 14671473.
    Citations: 36     Fields:    Translation:HumansCTClinical Trials
  82. Parad RB, Comeau AM. Newborn screening for cystic fibrosis. Pediatr Ann. 2003 Aug; 32(8):528-35. PMID: 12942895.
    Citations: 2     Fields:    Translation:HumansPHPublic Health
  83. Davis JM, Parad RB, Michele T, Allred E, Price A, Rosenfeld W. Pulmonary outcome at 1 year corrected age in premature infants treated at birth with recombinant human CuZn superoxide dismutase. Pediatrics. 2003 Mar; 111(3):469-76. PMID: 12612223.
    Citations: 55     Fields:    Translation:HumansCTClinical Trials
  84. Ward VL, Barnewolt CE, Estroff JA, Levine D, Mehta TS, Parad RB. Work-in-Progress for the SPR Millennium Grant: Fetal MR of Chest Masses. Pediatric Radiology. 2003.
  85. Parad RB and Comeau AM. Cystic Fibrosis Newborn Screening. Pediatric Annals. 2003; 32(8):528-35.
  86. Ward VL, Barnewolt CE, Estroff JA, Levine D, Mehta TS, Parad RB. Work-in-Progress for the SPR Millennium Grant: Fetal MR of Chest Masses. The Society for Pediatric Radiology. 2003.
  87. Parad RB, Comeau A, Dorkin H, Dovey M, Martin T, Gerstle R, O’Sullivan B. Outcome after an initial borderline sweat test in hypertrypsinogenemic infants detected through CF newborn screening. Pediatric Pulmonology. 2003; sup: 222-223.
  88. Parad R. Bronchopulmonary Dysplasia (Chronic Lung Disease). Manual of Neonatal Care (Cloherty JP, Eichenwald, EC, Stark AR, editors). 2003.
  89. Comeau A, Parad RB, Dorkin H, Dovey M, Haver K, Lapey A, Gerstle R, O’Sullivan B. Increased sensitivity at the cost of increased referrals when population-based newborn screening incorporates testing for multiple allele mutations (MM): Cystic Fibrosis (CF) newborn screening (NBS) as a model. Am J Hum Genet. 2003; (73):( 5 sup ): 213.
  90. Cullen A, Van Marter LJ, Allred EN, Moore M, Parad RB, Sunday ME. Urine bombesin-like peptide elevation precedes clinical evidence of bronchopulmonary dysplasia. Am J Respir Crit Care Med. 2002 Apr 15; 165(8):1093-7. PMID: 11956050.
    Citations: 10     Fields:    Translation:Humans
  91. Parad, R. An Unexpected Screening Result© (IN703.3). 2002.
  92. Davis JM, Parad R. The role of oxidant injury in the pathogenesis of bronchopulmonary dysplasia. Basic Mechanisms of Pediatric Respiratory Disease (Haddad GG, Abman SH, Chernick V, editors). 2002; 505-517.
  93. Wheeler PG, Smith R, Dorkin H, Parad RB, Comeau AM, Bianchi DW. Genetic counseling after implementation of statewide cystic fibrosis newborn screening: Two years' experience in one medical center. Genet Med. 2001 Nov-Dec; 3(6):411-5. PMID: 11715005.
    Citations: 8     Fields:    Translation:HumansPHPublic Health
  94. Van Marter LJ, Allred EN, Leviton A, Pagano M, Parad R, Moore M. Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants. J Pediatr. 2001 Feb; 138(2):198-204. PMID: 11233077.
    Citations: 4     Fields:    Translation:Humans
  95. Van Marter LJ, Allred EN, Pagano M, Sanocka U, Parad R, Moore M, Susser M, Paneth N, Leviton A. Do clinical markers of barotrauma and oxygen toxicity explain interhospital variation in rates of chronic lung disease? The Neonatology Committee for the Developmental Network. Pediatrics. 2000 Jun; 105(6):1194-201. PMID: 10835057.
    Citations: 64     Fields:    Translation:Humans
  96. Davis JM, Richter SE, Biswas S, Rosenfeld WN, Parton L, Gewolb IH, Parad R, Carlo W, Couser RJ, Baumgart S, Atluru V, Salerno L, Kassem N. Long-term follow-up of premature infants treated with prophylactic, intratracheal recombinant human CuZn superoxide dismutase. J Perinatol. 2000 Jun; 20(4):213-6. PMID: 10879331.
    Citations: 7     Fields:    Translation:Humans
  97. Parad RB, Gerard CJ, Zurakowski D, Nichols DP, Pier GB. Pulmonary outcome in cystic fibrosis is influenced primarily by mucoid Pseudomonas aeruginosa infection and immune status and only modestly by genotype. Infect Immun. 1999 Sep; 67(9):4744-50. PMID: 10456926.
    Citations: 43     Fields:    Translation:HumansCells
  98. Chiba-Falek O, Parad RB, Kerem E, Kerem B. Variable levels of normal RNA in different fetal organs carrying a cystic fibrosis transmembrane conductance regulator splicing mutation. Am J Respir Crit Care Med. 1999 Jun; 159(6):1998-2002. PMID: 10351951.
    Citations: 4     Fields:    Translation:HumansCells
  99. Parad RB. Developing fetal diagnostic techniques. Prenatal Care (McCormick MC, Siegel JE, editors). 1999; 231-243.
  100. Parad RB. Buccal cell DNA mutation analysis for diagnosis of cystic fibrosis in newborns and infants inaccessible to sweat chloride measurement. Pediatrics. 1998 May; 101(5):851-5. PMID: 9565413.
    Citations: 2     Fields:    Translation:Humans
  101. Davis JM, Rosenfeld WN, Richter SE, Parad MR, Gewolb IH, Spitzer AR, Carlo WA, Couser RJ, Price A, Flaster E, Kassem N, Edwards L, Tierney J, Horowitz S. Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics. 1997 Jul; 100(1):24-30. PMID: 9200356.
    Citations: 18     Fields:    Translation:HumansCTClinical Trials
  102. Parad R, Berger T. Chronic Lung Disease. Manual of Neonatal Care (Cloherty JP, Stark AR, editors). 1997; 378-388.
  103. Davis JM, Rosenfeld W, Richter SE, Parad RB, Gewolb IH, Spitzer A, Carlo W, Couser R, Price A, Flaster E, Kassem N, Edwards L, Tierney J, Horowitz S. . Safety and pharmacokinetics of multiple doses of recombinant human CuZn superoxide dismutase administered intratracheally to premature neonates with respiratory distress syndrome. Pediatrics. 1997; 100:24-30.
  104. Parad RB. Heterogeneity of phenotype in two cystic fibrosis patients homozygous for the CFTR exon 11 mutation G551D. J Med Genet. 1996 Aug; 33(8):711-3. PMID: 8863168.
    Citations: 3     Fields:    Translation:Humans
  105. Bromley B, Parad R, Estroff JA, Benacerraf BR. Fetal lung masses: prenatal course and outcome. J Ultrasound Med. 1995 Dec; 14(12):927-36; quiz p1378. PMID: 8583529.
    Citations: 8     Fields:    Translation:Humans
  106. Estroff JA, Parad RB, Barnes PD, Madsen JP, Benacerraf BR. Posterior fossa arachnoid cyst: an in utero mimicker of Dandy-Walker malformation. J Ultrasound Med. 1995 Oct; 14(10):787-90. PMID: 8544249.
    Citations: 1     Fields:    Translation:Humans
  107. Parad RB, Applegate K, Doubilet PM, Fishman SJ, Estroff JA. Occult fetal bowel obstruction: ileal atresia presenting in a newborn infant after normal antenatal sonography. J Ultrasound Med. 1995 Feb; 14(2):161-3. PMID: 8568964.
    Citations:    Fields:    Translation:Humans
  108. Parad RB . Applications of genetic information regarding the gene responsible for cystic fibrosis (Part 2). The International Association of Cystic Fibrosis Adults Newsletter. 1995; (41):3-9.
  109. Estroff JA, Parad RB, Share JC, Benacerraf BR. Second trimester prenatal findings in duodenal and esophageal atresia without tracheoesophageal fistula. J Ultrasound Med. 1994 May; 13(5):375-9. PMID: 8015045.
    Citations: 2     Fields:    Translation:Humans
  110. Parad RB. Applications of genetic information regarding the gene responsible for cystic fibrosis (Part 1). The International Association of Cystic Fibrosis Adults Newsletter. 1994; (40):3-8.
  111. The Cystic Fibrosis Genetic Analysis Consortium, Population variation of common cystic fibrosis mutations. Hum Mutat. 1994; 4:167-77.
  112. Richards B, Skoletsky J, Shuber AP, Balfour R, Stern RC, Dorkin HL, Parad RB, Witt D, Klinger KW. Multiplex PCR amplification from the CFTR gene using DNA prepared from buccal brushes/swabs. Hum Mol Genet. 1993 Feb; 2(2):159-63. PMID: 7684637.
    Citations: 80     Fields:    Translation:HumansCells
  113. Estroff JA, Parad RB, Teele RL, Benacerraf BR. Echogenic vessels in the fetal thalami and basal ganglia associated with cytomegalovirus infection. J Ultrasound Med. 1992 Dec; 11(12):686-8. PMID: 1337361.
    Citations: 2     Fields:    Translation:Humans
  114. Davis AE, Aulak K, Parad RB, Stecklein HP, Eldering E, Hack CE, Kramer J, Strunk RC, Bissler J, Rosen FS. C1 inhibitor hinge region mutations produce dysfunction by different mechanisms. Nat Genet. 1992 Aug; 1(5):354-8. PMID: 1363816.
    Citations: 9     Fields:    Translation:HumansAnimalsCells
  115. Estroff JA, Parad RB, Benacerraf BR. Prevalence of cystic fibrosis in fetuses with dilated bowel. Radiology. 1992 Jun; 183(3):677-80. PMID: 1584918.
    Citations: 3     Fields:    Translation:Humans
  116. Bromley B, Estroff JA, Sanders SP, Parad R, Roberts D, Frigoletto FD, Benacerraf BR. Fetal echocardiography: accuracy and limitations in a population at high and low risk for heart defects. Am J Obstet Gynecol. 1992 May; 166(5):1473-81. PMID: 1595802.
    Citations: 19     Fields:    Translation:Humans
  117. Estoff JA, Parad RB, Frigoletto FD, Benacerraf BR. The natural history of isolated fetal hydrothorax. Ultrasound Obstet Gynecol. 1992 May 01; 2(3):162-5. PMID: 12796967.
    Citations: 1     Fields:    
  118. Parad RB. Ontogeny of nonimmune defense mechanisms. Semin Perinatol. 1992 Apr; 16(2):97-105. PMID: 1636130.
    Citations:    Fields:    Translation:Humans
  119. Parad RB, Gerard C. A sequence variation in intron 17B of the cystic fibrosis transmembrane conductance regulator gene. Hum Mutat. 1992; 1(3):258-9. PMID: 1284536.
    Citations: 1     Fields:    Translation:HumansCells
  120. Davis E, III, Aulak K, Parad RB, Stecklein HP, Eldering E, Hack CE, Kramer J, Strunk RC, Bissler J, Rosen FS. . C1 Inhibitor hinge region mutations may convert the inhibitor to a substrate or may result in the inability to interact with target proteases. Nat Genet. 1992; 1:354-58.
  121. Parad, R, Ringer, S. Neonatology Core Curriculum, Volume III (2008 edition). 1991.
  122. Parad, R, Ringer, S. Neonatology Core Curriculum, Volume II (2008 edition). 1991.
  123. Parad R. Chronic Lung Disease (formerly Bronchopulmonary Dysplasia). Manual of Neonatal Care (Cloherty JP, Stark AR, editors). 1991; 237-246.
  124. Johnson, L, Keefer, C, Parad, R and O'Brien, S. Neonatology Core Curriculum, Volume I (2005 edition). 1991.
  125. Parad RB, Kramer J, Strunk RC, Rosen FS, Davis AE. Dysfunctional C1 inhibitor Ta: deletion of Lys-251 results in acquisition of an N-glycosylation site. Proc Natl Acad Sci U S A. 1990 Sep; 87(17):6786-90. PMID: 2118657.
    Citations: 9     Fields:    Translation:HumansCells
  126. Parad RB, Wohl MEB. . Bronchopulmonary dysplasia. Curr Opin Pediatr. 1990; (2):459-464.
  127. O'Rourke PP, Crone RK, Vacanti JP, Ware JH, Lillehei CW, Parad RB, Epstein MF. Extracorporeal membrane oxygenation and conventional medical therapy in neonates with persistent pulmonary hypertension of the newborn: a prospective randomized study. Pediatrics. 1989 Dec; 84(6):957-63. PMID: 2685740.
    Citations: 44     Fields:    Translation:HumansCTClinical Trials
  128. Ariga T, Igarashi T, Ramesh N, Parad R, Cicardi M, Davis AE. Type I C1 inhibitor deficiency with a small messenger RNA resulting from deletion of one exon. J Clin Invest. 1989 Jun; 83(6):1888-93. PMID: 2723063.
    Citations: 7     Fields:    Translation:HumansCells
  129. Gitlin JD, Soll RF, Parad RB, Horbar JD, Feldman HA, Lucey JF, Taeusch HW. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics. 1987 Jan; 79(1):31-7. PMID: 3540835.
    Citations: 22     Fields:    Translation:HumansAnimalsCTClinical Trials
  130. Fox R, Parad R, Demling R, Merrigan M. Increased permeability of isolated rat lungs perfused with an oxygen radical generator (purine-xanthine oxidase) under constant pressure conditions. Physiology of Oxygen Radicals (Taylor A, editor). 1986.
  131. Gitlin JD, Parad R, Taeusch HW. Exogenous surfactant therapy in hyaline membrane disease. Semin Perinatol. 1984 Oct; 8(4):272-82. PMID: 6387924.
    Citations:    Fields:    Translation:HumansAnimalsCTClinical Trials
  132. Richard B. Parad. Marihuana and the Lungs: Combined Effects of Marihuana and Alcohol on Pulmonary Host Defense Mechanisms. (Thesis approved for Honors in Biology). 1977.
  133. Parad R, Simmons G, Feldman N, Huber G. Impairment of adaptive tolerance to oxygen toxicity by systemic immunosuppression. Chest. 1975 Feb; 67(2 Suppl):42S-43S. PMID: 1112107.
    Citations: 1     Fields:    Translation:Animals
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Parad's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (369)
Explore
_
Co-Authors (57)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.